Neuroprotective Gene Therapy by Overexpression of the Transcription Factor MAX in Rat Models of Glaucomatous Neurodegeneration

PURPOSE: Based on our preview evidence that reduced nuclear content of the transcription factor Myc-associated protein X (MAX) is an early event associated with degeneration of retinal ganglion cells (RGCs), in the present study, our purpose was to test whether the overexpression of human MAX had a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lani-Louzada, Rafael, Marra, Camila, Dias, Mariana Santana, de Araújo, Victor Guedes, Abreu, Carla Andreia, Ribas, Vinícius Toledo, Adesse, Daniel, Allodi, Silvana, Chiodo, Vince, Hauswirth, William, Petrs-Silva, Hilda, Linden, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Glaucoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819487/
https://www.ncbi.nlm.nih.gov/pubmed/35103748
http://dx.doi.org/10.1167/iovs.63.2.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819487/
https://www.ncbi.nlm.nih.gov/pubmed/35103748
http://dx.doi.org/10.1167/iovs.63.2.5

Ejemplares similares